The Arab Drug Company (EGX:ADCI)

Revenue by Segment

Financials in millions EGP. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016
Pharmaceuticals	1.12B	785.52M	633.73M	505.04M	537.05M
Pharmaceuticals Growth	42.35%	23.95%	25.48%	-5.96%	3.12%
Total	1.12B	785.52M	633.73M	505.04M	537.05M
Total Growth	42.35%	23.95%	25.48%	-5.96%	3.12%

Revenue by Geography

Financials in millions EGP. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016
Egypt	1.12B	785.52M	633.73M	505.04M	537.05M
Egypt Growth	42.35%	23.95%	25.48%	-5.96%	3.12%
Total	1.12B	785.52M	633.73M	505.04M	537.05M
Total Growth	42.35%	23.95%	25.48%	-5.96%	3.12%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 15, 2026

Data Sources Report a data error